WO2001042471A3 - Polypeptides and polynucleotides encoding same - Google Patents
Polypeptides and polynucleotides encoding same Download PDFInfo
- Publication number
- WO2001042471A3 WO2001042471A3 PCT/US2000/033463 US0033463W WO0142471A3 WO 2001042471 A3 WO2001042471 A3 WO 2001042471A3 US 0033463 W US0033463 W US 0033463W WO 0142471 A3 WO0142471 A3 WO 0142471A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptides
- polynucleotides encoding
- nov
- encoding same
- polynucleotide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Pregnancy & Childbirth (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Virology (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU19578/01A AU1957801A (en) | 1999-12-09 | 2000-12-08 | Novel polypeptides and polynucleotides encoding same |
EP00982559A EP1235908A2 (en) | 1999-12-09 | 2000-12-08 | Polypeptides and polynucleotides encoding same |
CA002394917A CA2394917A1 (en) | 1999-12-09 | 2000-12-08 | Polypeptides and polynucleotides encoding same |
JP2001544344A JP2003527840A (en) | 1999-12-09 | 2000-12-08 | Polypeptides and polynucleotides encoding them |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16988799P | 1999-12-09 | 1999-12-09 | |
US60/169,887 | 1999-12-09 | ||
US17023099P | 1999-12-10 | 1999-12-10 | |
US60/170,230 | 1999-12-10 | ||
US09/732,436 | 2000-12-07 | ||
US09/732,436 US20030064919A1 (en) | 1999-12-09 | 2000-12-07 | Novel polypeptides and polynucleotides encoding same |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001042471A2 WO2001042471A2 (en) | 2001-06-14 |
WO2001042471A8 WO2001042471A8 (en) | 2001-11-29 |
WO2001042471A3 true WO2001042471A3 (en) | 2002-04-25 |
Family
ID=27389736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/033463 WO2001042471A2 (en) | 1999-12-09 | 2000-12-08 | Polypeptides and polynucleotides encoding same |
Country Status (4)
Country | Link |
---|---|
US (1) | US20030064919A1 (en) |
JP (1) | JP2003527840A (en) |
CA (1) | CA2394917A1 (en) |
WO (1) | WO2001042471A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001072827A2 (en) * | 2000-03-24 | 2001-10-04 | Millennium Pharmaceuticals, Inc. | 33395, a human leucine-rich repeat family member and use thereof |
EP1382347A1 (en) * | 2002-07-17 | 2004-01-21 | UNIVERSITE PARIS 7 - Denis DIDEROT | Use of CCN protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux |
EP3303559A1 (en) * | 2015-06-01 | 2018-04-11 | Biogen MA Inc. | Manganese supplementation for control of glycosylation in mammalian cell culture process |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996035789A1 (en) * | 1995-05-10 | 1996-11-14 | The Women's Research Institute | Human interferon tau compositions and methods of use |
-
2000
- 2000-12-07 US US09/732,436 patent/US20030064919A1/en not_active Abandoned
- 2000-12-08 WO PCT/US2000/033463 patent/WO2001042471A2/en not_active Application Discontinuation
- 2000-12-08 JP JP2001544344A patent/JP2003527840A/en not_active Withdrawn
- 2000-12-08 CA CA002394917A patent/CA2394917A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996035789A1 (en) * | 1995-05-10 | 1996-11-14 | The Women's Research Institute | Human interferon tau compositions and methods of use |
Non-Patent Citations (2)
Title |
---|
HIMMLER A. ET AL.: "Molecular cloning and expression in Escherichia coli of equine type-I Interferons", DNA, vol. 5, no. 5, 1986, pages 345 - 356, XP000914990, ISSN: 1044-5498 * |
LEFÈVRE F. ET AL.: "A novel and atypical type one Interferon gene expressed by trophoblast during early pregnancy", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 268, no. 26, 15 September 1993 (1993-09-15), pages 19760 - 19768, XP002174153, ISSN: 0021-9258 * |
Also Published As
Publication number | Publication date |
---|---|
JP2003527840A (en) | 2003-09-24 |
US20030064919A1 (en) | 2003-04-03 |
CA2394917A1 (en) | 2001-06-14 |
WO2001042471A8 (en) | 2001-11-29 |
WO2001042471A2 (en) | 2001-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001092523A3 (en) | Human polynucleotides and polypeptides encoded thereby | |
WO2000058473A3 (en) | Nucleic acids including open reading frames encoding polypeptides; 'orfx' | |
WO2001007595A3 (en) | Novel fibroblast growth factor and nucleic acids encoding same | |
WO2001010902A8 (en) | Nucleoc acids and secreted polypeptides encoded thereby | |
WO2001090366A3 (en) | Human polynucleotides and polypeptides encoded thereby | |
WO2001036645A3 (en) | Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same | |
WO2000053742A3 (en) | Polynucleotides and proteins encoded thereby | |
WO2002066647A3 (en) | Type 2 ctokine receptor and nucleic acids encoding same | |
WO2001049729A8 (en) | Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use | |
WO2000078802A3 (en) | Secreted polypeptides and corresponding polynucleotides | |
WO2001074856A3 (en) | Wnt-7b-like polypeptides and nucleic acids encoding same | |
WO2002002625A3 (en) | Novel fibroblast growth factors and nucleic acids encoding same | |
WO2001085767A3 (en) | Human proteins polynucleotides encoding them and methods of using the same | |
WO2001005971A3 (en) | Secreted polypeptides and corresponding polynucleotides | |
WO2001070978A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2001062928A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2001042471A3 (en) | Polypeptides and polynucleotides encoding same | |
WO2001061009A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2001044473A3 (en) | Polypeptides and nucleic acids encoding same | |
WO2000061754A3 (en) | Human proteins and polynucleotides encoding them | |
WO2001036638A8 (en) | Polypeptides and nucleic acids encoding same | |
WO2001079294A3 (en) | Human proteins, polynucleotides encoding them and methods of using the same | |
WO2000070046A3 (en) | Secreted polypeptides and corresponding polynucleotides | |
WO2001019856A3 (en) | Secreted human proteins, polynucleotides encoding them and methods of using the same | |
WO2001023561A3 (en) | Novel polynucleotides encoding proteins containing thrombospondin type 1 repeats |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 24/2001 UNDER (30) REPLACE "NOT FURNISHED" BY "09/732436" |
|
WWE | Wipo information: entry into national phase |
Ref document number: 19578/01 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2394917 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 544344 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000982559 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000982559 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000982559 Country of ref document: EP |